121 related articles for article (PubMed ID: 20008060)
1. Barriers to follow-up of abnormal Papanicolaou smears among women in Leon, Nicaragua.
Vastbinder MB; Castillo C; Bekkers RL
Trop Doct; 2010 Jan; 40(1):22-6. PubMed ID: 20008060
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
Campos NG; Mvundura M; Jeronimo J; Holme F; Vodicka E; Kim JJ
BMJ Open; 2017 Jun; 7(6):e015048. PubMed ID: 28619772
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
[TBL] [Abstract][Full Text] [Related]
4. Contribution of health care coverage in cervical cancer screening follow-up: findings from a cross-sectional study in Colombia.
Garcés-Palacio IC; Altarac M; Kirby R; McClure LA; Mulvihill B; Scarinci IC
Int J Gynecol Cancer; 2010 Oct; 20(7):1232-9. PubMed ID: 21495237
[TBL] [Abstract][Full Text] [Related]
5. A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer.
Jeronimo J; Bansil P; Lim J; Peck R; Paul P; Amador JJ; Mirembe F; Byamugisha J; Poli UR; Satyanarayana L; Asthana S;
Int J Gynecol Cancer; 2014 Mar; 24(3):576-85. PubMed ID: 24557438
[TBL] [Abstract][Full Text] [Related]
6. Follow-up care of women with an abnormal cytology in a low-resource setting.
Gage JC; Ferreccio C; Gonzales M; Arroyo R; Huivín M; Robles SC
Cancer Detect Prev; 2003; 27(6):466-71. PubMed ID: 14642555
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of visual inspection with acetic acid and Lugol's iodine as cervical cancer screening tools in a low-resource setting.
Qureshi S; Das V; Zahra F
Trop Doct; 2010 Jan; 40(1):9-12. PubMed ID: 20008057
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening with liquid cytology in women with developmental disabilities.
Kavoussi SK; Smith YR; Ernst SD; Quint EH
J Womens Health (Larchmt); 2009; 18(1):115-8. PubMed ID: 19072727
[TBL] [Abstract][Full Text] [Related]
9. Incidence of abnormal cervical and vaginal cytology among women over age 65 years living with human immunodeficiency virus.
Stewart KA; Allen SM; Chesnokova AE; Syed F; Levison JE
Am J Obstet Gynecol; 2020 May; 222(5):486.e1-486.e10. PubMed ID: 31678094
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of abnormal cervical cytology by liquid based cytology in the antenatal care clinic, Thammasat University Hospital.
Khaengkhor P; Mairaing K; Suwannarurk K; Thaweekul Y; Poomtavorn Y; Pattaraarchachai J; Bhamarapravatana K
J Med Assoc Thai; 2011 Feb; 94(2):152-8. PubMed ID: 21534360
[TBL] [Abstract][Full Text] [Related]
11. Performance of the acetic acid test when used in field conditions as a screening test for cervical cancer.
Claeys P; De Vuyst H; Gonzalez C; Garcia A; Bello RE; Temmerman M
Trop Med Int Health; 2003 Aug; 8(8):704-9. PubMed ID: 12869091
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
[TBL] [Abstract][Full Text] [Related]
13. Agreement between visual inspection with acetic acid and Papanicolaou's smear as screening methods for cervical cancer.
Naz U; Hanif S
J Coll Physicians Surg Pak; 2014 Apr; 24(4):228-31. PubMed ID: 24709232
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
Bakari F; Abdul MA; Ahmed SA
Ann Afr Med; 2017; 16(2):74-80. PubMed ID: 28469121
[TBL] [Abstract][Full Text] [Related]
15. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
[TBL] [Abstract][Full Text] [Related]
16. [The results of screening program for cervical cancer in Lodz].
Gottwald L; Giernat L; Lech W; Wójcik-Krowiranda K; Akoel KM; Kowalczyk-Amico K; Estemberg D; Grzesiak M; Sosnowski D; Guzowski G; Baś E; Tyliński W; Bieńkiewicz A
Ginekol Pol; 2002 Nov; 73(11):934-8. PubMed ID: 12722377
[TBL] [Abstract][Full Text] [Related]
17. [Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence].
Dumont A; Bessières N; Benbassa A; Razafindrafara G; Rabearison F; Philippe HJ
J Gynecol Obstet Hum Reprod; 2017 Apr; 46(4):327-332. PubMed ID: 28643659
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
[TBL] [Abstract][Full Text] [Related]
19. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
[TBL] [Abstract][Full Text] [Related]
20. Screening for cervical cancer in the developing world.
Cronjé HS
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):517-29. PubMed ID: 16150391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
